Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06785870 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EVAluation of Erythrocytosis PRospEctive Cohort STudy

Study acronym: EVEREST
StatusNot Yet Recruiting
PhaseNot specified
SponsorCyrus Hsia
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 21, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The EValuation of ERythrocytosis pRospEctive cohort STudy (EVEREST) is a prospective study designed to shed light on these key questions in the diagnosis, management, and clinical outcomes in patients with elevated hemoglobin (erythrocytosis). This longitudinal, prospective study will generate high quality data that can help inform the optimal approach to diagnosis and management in this patient population.
Trial Details
NCT Number NCT06785870
Lead Sponsor Cyrus Hsia
Conditions
(from sponsor)		 Erythrocytosis, Polycythemia, Polycythemia Secondary, Polycythemia Vera, Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Polycythemia Vera (PV), Polycythemia; Familial, Polycythemia, Primary
Related terms Disease, Polycythemia, Polycythemia Vera, Polycythemia, primary familial and congenital
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov